| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/18/2004 | CN1475221A Luerythromycin oculentum |
| 02/18/2004 | CN1475220A Clamycin medicinal preparation |
| 02/18/2004 | CN1475219A Medicinal composition for treating blood vessel disease |
| 02/18/2004 | CN1475218A Medicinal preparation composed of diphosphate and aminoglucose salt and its use |
| 02/18/2004 | CN1475217A Application of N-acetyl-D-aminoglucose in the preparation of medicine for treating urogenital system infection |
| 02/18/2004 | CN1475216A Egg yolk lecithin soft capsule and its production process |
| 02/18/2004 | CN1475215A Enosaxin for injection and its preparation method |
| 02/18/2004 | CN1475214A Application of amyl ethyl quin ether hydrochloride |
| 02/18/2004 | CN1475213A Soyisoflavone soft capsule and its preparation technology |
| 02/18/2004 | CN1475212A Compound preparation of levocarnitine and calcium pantothenate |
| 02/18/2004 | CN1475211A Compound preparation of levocarnitine and coenzyme Q10 |
| 02/18/2004 | CN1475210A New use of agmatine |
| 02/18/2004 | CN1475209A Slow-released agent form of sertraline |
| 02/18/2004 | CN1475208A Slow-released agent form of sertraline |
| 02/18/2004 | CN1475207A Solid oral dosage mode containing walshaden and hydrochloric thizaine |
| 02/18/2004 | CN1475206A Medical composition containing micropowdery bicyclic medicine |
| 02/18/2004 | CN1475205A Medicine conveying system--preparation method of solid nano medicine |
| 02/18/2004 | CN1138787C Natural plant polyose |
| 02/18/2004 | CN1138784C Action of antisense nucleic acid pointing at urokinase type plasminogen activating agent gene for inhibiting cancer |
| 02/18/2004 | CN1138781C Process for recovery cephalosporin from fermentative liquid |
| 02/18/2004 | CN1138780C Thienopyrimidines |
| 02/18/2004 | CN1138779C Substituted triazolo-pyridazing derivative, pharmaceutical composition made therefrom |
| 02/18/2004 | CN1138778C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 02/18/2004 | CN1138775C Acetylcholine enhancers and its use |
| 02/18/2004 | CN1138774C Substituted 6,6-hetero-bicyclic derivatives |
| 02/18/2004 | CN1138773C 4-alkenyl (and alkynyl) oxindoles as inhibitors of cell cycle protein dependent kinases, in particular CDK2 |
| 02/18/2004 | CN1138771C 6-hydroxy-3-(4-[2-piperidine-1-group) oxyethyl group] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride salt |
| 02/18/2004 | CN1138770C 6-carbonyl-3-(4-[2-pierid-1-yl)elhoyl]phenoxy)-2-(4-methoxylphenyl) benzo[b] thiophene salt crystal |
| 02/18/2004 | CN1138765C Oxazolidinone antibacterial agents having thiocarbonyl functionality |
| 02/18/2004 | CN1138764C Isoxazole derivatives |
| 02/18/2004 | CN1138761C 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and use as dopamine autoreceptor (D2) agonists |
| 02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 02/18/2004 | CN1138759C Novel process |
| 02/18/2004 | CN1138755C Cyclic amino acids and derivs thereof useful as pharmaceutical agents |
| 02/18/2004 | CN1138753C Dimethyl-substituted cyclohexane diene derivatives |
| 02/18/2004 | CN1138591C Coated particles, method of making and using |
| 02/18/2004 | CN1138579C Diffusional implantable delivery system |
| 02/18/2004 | CN1138557C New use of ginseng and ginseng stalk and leaf extractive in preventing and treating osteoposis |
| 02/18/2004 | CN1138556C Medicinal composition for treating anorectal cencer and its preparing process |
| 02/18/2004 | CN1138552C Polyphenol extract of tea, use thereof and formulations containing same |
| 02/18/2004 | CN1138548C Crustaceous extract health care foods and preparation method thereof |
| 02/18/2004 | CN1138547C Hormonal medicaments for correcting oestrogen deficiencies |
| 02/18/2004 | CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 02/18/2004 | CN1138545C Use of penciclovir for treatment of human herpes-virus-8 |
| 02/18/2004 | CN1138544C Drug composition for treatment and prevention of hepatopathy |
| 02/18/2004 | CN1138543C Lyophilizate of lipid complex of water insoluble camptothecins |
| 02/18/2004 | CN1138542C Method for stabilizing pharmaceutical composition by special use of antioxidant |
| 02/18/2004 | CN1138541C Pharmaceutically stable oxaliplatinum prepn. |
| 02/18/2004 | CN1138540C Antalgic and sedative oral etomidate preparation |
| 02/18/2004 | CN1138539C Use of basic amino acids and derivatives for lowering ceramide levels |
| 02/18/2004 | CN1138538C Antiviral agents |
| 02/18/2004 | CN1138537C Probucol clathrate capsule and its prepn. process |
| 02/18/2004 | CN1138536C Oil/water fat emulsion or its application of freeze dry composition |
| 02/18/2004 | CN1138535C Pharmaceutical compositions contg. effervescent acid -base couple |
| 02/18/2004 | CN1138534C Multiple unit tableted dosage |
| 02/18/2004 | CN1138531C Dispersible macromolecule compositions and method for their preparation and use |
| 02/18/2004 | CN1138529C Fizzy formulation |
| 02/18/2004 | CN1138527C Osmotic device with delayed activation of drug delivery and complete drug release |
| 02/18/2004 | CN1138526C Intravaginal drug delivery devices for administration of 17 beta-oestradiol precursors |
| 02/18/2004 | CN1138505C Anti-angiogenic compositions and method of use |
| 02/17/2004 | US6693207 5,7,9-estratriene derivative having atleast one sulfate salt at 3 or 17 position of the ring; anti-osteoporosis compound |
| 02/17/2004 | US6693202 Multibinding ligands containing such as amine, amide, ester, hydroxyl, carbamate, urea and/or imino functionality |
| 02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
| 02/17/2004 | US6693198 Using early incorporation of organic acids for rapid isolation and purification of intermediates; improved bulk density, flocculence, compressibility and water solubility |
| 02/17/2004 | US6693193 Coupling an n- and o-protected 2,3-dihydroxy-pyrrolidine to the 2-position and deprotecting |
| 02/17/2004 | US6693192 Hypolipidemic and antioxidant morpholine derivatives |
| 02/17/2004 | US6693186 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
| 02/17/2004 | US6693183 MURINE α (1,3) FUCOSYLTRANSFERASE FUC-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 02/17/2004 | US6693135 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 02/17/2004 | US6693134 Bicyclic aromatic chemokine receptor ligands |
| 02/17/2004 | US6693132 Methods for using alkanoyloxymethyl esters |
| 02/17/2004 | US6693130 Inhibitors of epoxide hydrolases for the treatment of hypertension |
| 02/17/2004 | US6693129 A biochemical formulation comprising ascorbic acid, niacin, lysine, and proline useful for lowering plasma concentration of a lipoprotein in mammal |
| 02/17/2004 | US6693128 Substituted dicinnamoylquinides and their use in augmentation of adenonsine function |
| 02/17/2004 | US6693127 Pharmaceutical compositions of arglabin and arglabin derivatives |
| 02/17/2004 | US6693126 Dihydroxyphenyl derivatives for hepatoprotection and treatment of liver diseases |
| 02/17/2004 | US6693125 Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders |
| 02/17/2004 | US6693122 Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
| 02/17/2004 | US6693121 As inhibitors of serine proteases of the coagulation cascade and compounds, used for anticoagulant therapy forprophylaxis of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases |
| 02/17/2004 | US6693119 Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties |
| 02/17/2004 | US6693118 E.G., 1-(2-(6,7-METHYLENEDIOXYNAPHTH-2-YL)-ETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE AND 1-2-(4-CYCLOHEXENYLPHENYL)-ETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6 -TETRAHYDROPYRIDINE; apoptosis inhibition; treatment of graft rejection or of acute or chronic rheumatoid arthritis |
| 02/17/2004 | US6693117 Compounds with analgesic effect |
| 02/17/2004 | US6693116 Adenosine receptor ligands |
| 02/17/2004 | US6693115 2-acetoxy-5-(alpha-cyclopropylcarbonyl-o-fluorobenzyl)--4,5,6,7 -tetrahydrothieno(3,2-c)-pyridine, particularly the hydrochloride and the maleate |
| 02/17/2004 | US6693114 N-(4-chlorobenzyl)-6-(3-hydroxy-1-propynyl)-1-7-dimethyl-4-oxo-1,4 -dihydro(1,8) naphthyridine-3-carboxamide for example; inhibiting viral dna polymerase; treating herpes virus infections |
| 02/17/2004 | US6693113 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections |
| 02/17/2004 | US6693112 Compounds for enhancing chemotherapy |
| 02/17/2004 | US6693111 Indole-2,3-dione-3-oxime derivatives |
| 02/17/2004 | US6693109 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 02/17/2004 | US6693108 Pyrimidinyl-guanidine derivatives |
| 02/17/2004 | US6693107 Pharmaceutical composition useful for the treatment of tinnitus and hearing loss |
| 02/17/2004 | US6693106 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (AGE's) |
| 02/17/2004 | US6693105 Using xanthinyl derivatives to reduce treatment induced toxicity; inhibiting cellular signaling through second messenger pathway; reducing cellular level of nonarachi-donate phosphatidic acid and diacylglycerol |
| 02/17/2004 | US6693104 Theobromine with an anti-carcinogenic activity |
| 02/17/2004 | US6693103 1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators |
| 02/17/2004 | US6693102 Pyridine-substituted pyrazolopyridine derivatives |
| 02/17/2004 | US6693101 Alkanoic acid derivative; integrin receptor antagonist |
| 02/17/2004 | US6693100 Using dexrazoxane |
| 02/17/2004 | US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| 02/17/2004 | US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |